Bennu Bioscience Private Limited - Due diligence report

A 360° intelligence report on Bennu Bioscience Private Limited: trust score, financial health, credit view, compliance, directors, growth an…

2018-09-25 Delhi, Delhi Active Unlisted
Connect MCP
Full Due-Diligence Report + Documents
  • Unlock all financial figures & 5-year trends
  • Full trust, health & credit-risk scores
  • Director details, charges & MCA documents
₹700 ₹449 Save ₹251 excl. GST
Or from ₹279/report with credits View credit packages
Company Credits – Starter
  • One credit unlocks this full due-diligence report
  • Use across any company’s report, anytime
  • Credits valid for 12 months
× ₹700 ₹279 = ₹2,790 60% off
Choose your own credit amount View credit packages

Bennu Bioscience Private Limited — 360° Intelligence Report

Generated from MCA filings & public records
72/100
Trust Score
Moderate

Bennu Bioscience Private Limited is assessed as Moderate with a Trust Score of 72/100. Bennu Bioscience Private Limited is an active private limited indian non-government company incorporated in 2018, operating in the Pharma sector. The company has shown revenue growth across its recent filed years. It was profitable in its latest filed year. Based on MCA filings and public records, it currently shows a low compliance risk and moderate financial risk profile.

Report generated on 18 Oct 2026 from the latest processed filings. Bennu Bioscience Private Limited snapshot & full profile →

Overall Assessment CautionWeakNeutralGoodStrong Strong

Automated indicators derived from public MCA / GST / EPFO records - not a credit rating, not investment, legal or financial advice. Spotted an inaccuracy? Report an error.

02

Score Card

Higher is safer · rule-based & explainable
Trust ScoreModerate
72/100
Overall counterparty trust - the headline number of this report.
Compliance ScoreLow Risk
81/100
Statutory standing - status, filings, auditor, MSME and litigation.
Financial Health ScoreModerate
50/100
Profitability, leverage and liquidity from filed statements.
Credit Risk ScoreModerate
55/100
Debt capacity, gearing and security cover for lenders.
Director Stability ScoreLow Risk
95/100
Board strength, DIN status, churn and network.
Growth ScoreLow Risk
95/100
Revenue, profit, asset and hiring momentum.
Distress ScoreModerate
60/100
Early-warning signals - higher means fewer warnings.
03

Financial Intelligence Dashboard

Standalone · 3 filed year(s)

Unlock the full 5-year financial dashboard with charts and year-wise figures.

Get full access

Scores and observations on this page are already computed from the real filings - only the underlying figures are locked.

04

Credit & Compliance Intelligence

Why the scores are what they are
Credit Risk Score: 55/100 Moderate
  • Liabilities ≈ 38% EBITDA - stretched.
  • No open charges - unencumbered balance sheet.
  • Profitable - internal accruals available.

Charges position: 0 open (-) · 0 satisfied (-).

Compliance Score: 81/100 Low Risk
  • Company status is Active as per MCA.
  • Balance sheet slightly behind (Mar 2025).
  • Litigation present in 1 court forum(s).
  • 1 active GST registration(s).
Legal cases on record (1)
05

Director Intelligence

Stability score: 95/100
NameDIN / PANDesignationAppointedTenureDIN status
RAJEEV KUMAR PATHAK 01234567 Director 01/04/2018 6 yrs Approved
YU ZHANG 01234567 Director 01/04/2018 6 yrs Approved
WEINI PA 01234567 Director 01/04/2018 6 yrs Approved
  • 3 directors on the board.
  • No disqualified or deactivated DINs.
  • Stable board - no exits in 3 years.
  • Average tenure above 5 years.
06

Ownership & Group Intelligence

As per FY 2020 annual return
Promoter holding
64.27%
Public / other holding
35.73%
Equity shares
12,45,67,890
Equity paid-up
124.5 cr
Promoters on record
4
Ultimate holding entity
-
Subsidiaries
-
Group entities
-
Capital events
-

Promoters hold a dominant controlling stake - exact percentages are part of the full report.

Full shareholding pattern, group structure & capital events →

07

Risk Intelligence Center

Growth 95 · Distress 60
Growth signals & trust indicators
Revenue acceleration: +1.42 over 2 year(s).
Latest year revenue grew 2.1x.
Profit expanded 24% year-on-year.
Asset base grew 0.86 - capacity expansion.
Net margin improved to 61%.
Operating for 8 years.
Active GST registration(s).
Distress signals & risk flags
Outside liabilities up 38% in a year.
Negative net worth.
1 court case(s) on record - see the legal section for details.
08

Stakeholder Verdicts

Vendor · Banker · Investor
Vendor due diligence72/100
Favourable indicators
Suitability as a supplier / customer counterparty.
  • Statutory record is clean.
  • 2 distress signal(s) - see Risk Center.
  • Financial filings available for verification.
Banker assessment60/100
Mixed indicators - deeper appraisal suggested
Indicative lending comfort for banks, NBFCs and trade credit.
  • Debt capacity assessed from filed statements.
  • No existing security registered - first-charge position available.
  • Compliance record supports lending.
Investor view74/100
Positive growth indicators
Growth quality and scalability through an investor lens.
  • 5 growth signal(s) detected.
  • Margin and return trends computable from filings.
  • Management team looks stable.
09

MCA Filings & Events Timeline

Latest 7 events
30 Sep 2025
Last AGM held
Annual general meeting
31 Mar 2025
Latest balance sheet
Filed with ROC
08 Sep 2021
Director ceased
YU ZHANG
15 May 2021
Director appointed
RAJEEV KUMAR PATHAK (Additional Director)
25 Sep 2018
Incorporated
Registered with Roc Delhi
Director appointed
YU ZHANG (Director)
Director appointed
WEINI PA (Director)
10

Key Observations

Auto-generated from the data above
Revenue grew 1.42 over the last 2 financial year(s).
Net profit margin moved from 2.1x to 24%.
Compliance record is strong - status, filings and flags are clean.
3 active director(s) / partner(s); board looks stable and experienced.
1 active GST registration(s) indicate ongoing business operations.
Promoters hold a dominant controlling stake as per the FY 2020 annual return.
11

Peers & Related Companies

Full peer comparison →
CompanyCINLocation
D.L. Network Marketing Private Limited U51399DL2001PTC112616 West Delhi, Delhi
Fast Builders And Promotors Private Limited U74899DL1995PTC067828 Delhi
Bhumica Chits Private Limited U65992DL1983PTC016469 Delhi
MAAREN CONSTERIO INDIA LLP ACA-7186 West Delhi, Delhi
Interglobe Spiritz India Private Limited U15500DL2011PTC227502 Delhi
Jai Balaji Protection And Manpower Solution Private Limited U93000DL2011PTC219195 Delhi
Clinch Investment Consultancy Private Limited U67120DL2013PTC256338 Delhi
Ashima Tech Private Limited U51909DL2003PTC119212 Delhi
Kts Marketing Private Limited U51909DL2008PTC180732 Delhi
Jishnu Pharmaceuticals Private Limited U24232DL1998PTC096784 Delhi
12

Who Uses This Report

CA · CS · Banker · Investor · Vendor
Chartered Accountants (CA)

Verify Bennu Bioscience Private Limited before audits and certifications: compliance score 81/100, filing history, auditor history and charge records in one place - instead of pulling each MCA form separately.

Company Secretaries (CS)

Track statutory health of Bennu Bioscience Private Limited: ACTIVE compliance status, annual-return recency, director DIN status, board churn and the events timeline - the inputs for secretarial audits and due-diligence certificates.

Bankers & NBFCs

Current banker verdict: Mixed indicators - deeper appraisal suggested. Credit risk score 55/100, existing charge position and lender relationships - a first-pass credit memo before formal appraisal.

Investors & Analysts

Investor view: Positive growth indicators. Growth score 95/100, margin trends, ownership structure and peer set for Bennu Bioscience Private Limited - screening before a deeper diligence.

Vendors & Procurement Teams

Vendor verdict: Favourable indicators. Trust score 72/100, distress signals and MSME payment-delay disclosures - know whether Bennu Bioscience Private Limited pays its suppliers before you extend credit terms.

Lawyers & Compliance Teams

Litigation footprint (1 case(s) on record), regulatory flags, charge documents trail and director networks for Bennu Bioscience Private Limited - groundwork for KYC, onboarding and disputes.

13

Frequently Asked Questions

Is Bennu Bioscience Private Limited an active company?

Bennu Bioscience Private Limited has MCA status “Active” with a compliance score of 81/100 (Low Risk).

Is Bennu Bioscience Private Limited financially healthy?

Bennu Bioscience Private Limited has a Financial Health Score of 50/100 (Moderate) based on its filed financial statements.

Should I do business with Bennu Bioscience Private Limited?

Its overall Trust Score is 72/100 (Moderate). Vendor verdict: Favourable indicators. Review the risk flags in the Risk Intelligence Center before deciding.

Who controls Bennu Bioscience Private Limited?

Promoters hold a dominant controlling stake - exact percentages are in the full report. 3 active director(s) are on record.

Does Bennu Bioscience Private Limited have loans or charges against its assets?

No charges are registered against this company - an unencumbered balance sheet.

Is Bennu Bioscience Private Limited up to date with its ROC filings?

Balance sheet slightly behind (Mar 2025). Overall compliance score: 81/100 (Low Risk).

Is it risky to lend to Bennu Bioscience Private Limited?

Its Credit Risk Score is 55/100 (Moderate). Banker verdict: Mixed indicators - deeper appraisal suggested.

Disclaimer: This report is generated automatically from MCA filings and public records as available in our system at the time of the last update. Scores, bands and verdicts are rule-based derived indicators of the underlying data - they are opinions generated by an algorithm, not statements of fact about the company, and are not credit ratings (within the meaning of SEBI regulations), audits, or investment, legal or financial advice. Verify from official sources and consult a qualified professional before any business, lending or investment decision. If you represent this company and believe any information is inaccurate or outdated, report it here and we will review promptly.